Georgia CTSA Newsletter
|
Trouble viewing this email? View on the web.
| |
| |
Georgia CTSA Weekly eRoundup
April 3, 2020
|
| |
| | | | "When faced with a rising number of COVID-19 patients under investigation and that have the disease in the Grady Memorial Hospital ICU, we had to quickly mobilize and have discussions with all of our critical care colleagues to determine how to redeploy intensivists. A critical care task force was assigned to this COVID-19 pandemic to evaluate the current status and where we needed to be to handle the surge of patients. We developed practice guidelines ... | | Read More | |
|
| |
| | | | Join this free webinar from 2:00-3:00 p.m. to earn the pros and cons of different commercialization strategies to help determine the best fit for your technology. Come with questions and receive feedback to better understand complex go-to-market strategies. Speaker: Katie Merritt, Principal, Business Development & Licensing at Medtronic. Please note all talks for the remainder of this series will be hosted via webinar. | | Register | |
|
| |
| | Hear what the Emory Office of Clinical Research and IRB are doing to assist with the current ramp down of clinical trials. | | View | |
| |
| | National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest to highlight the urgent need for research on the 2019 novel coronavirus and the disease it causes. NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial. | | Read More | |
| |
| | LifeArc has made available an initial £10M for the identification of therapeutics that can be rapidly deployed to treat COVID-19. Tell us about your project and how it will address the needs of COVID-19 patients during this pandemic. | | Read More | |
| |
| | Pfizer Global Medical Grants (GMG) supports the global healthcare community's independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer's medical and/or scientific strategies. Projects that will be considered for Pfizer support will focus on increasing the understanding of targeted therapies including BRAF inhibitors and their use in the treatment of colorectal cancer (CRC). | | Read More | |
| |
| | This RFP is intended to support quality improvement (QI) initiatives that focus on the implementation of updated pneumococcal immunization recommendations, as described in the updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for adult pneumococcal immunization. | | Read More | |
| |
| | The funding priority for the seed grants from the Emory-Georgia Tech Healthcare Innovation Program will be for proposals that address issues in dealing with pandemics such as (but not limited to): coordination of public health and healthcare systems in clinical responses, diagnostic testing, provider-patient safety; improving clinical preparedness and communication; impact on healthcare system physicians, nurses, staff. | | Read More | |
| |
| | In light of the current COVID-19 outbreak, the dean of the Emory School of Medicine (SOM) has created a special grant cycle of the Dean’s Imagine, Innovate, and Impact (I3) Awards. This I3 Rapid RFP will specifically support the creation of data in preparation for anticipated external funding opportunities related to COVID-19. | | Read More | |
| |
| | Pfizer Global Medical Grants (GMG) supports the global healthcare community's independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer's medical and/or scientific strategies. Projects that will be considered for Pfizer support will focus on increasing the understanding of MAPK pathway inhibitors and their use in the treatment of melanoma. | | Read More | |
| |
| | (NOTE: Emory DoM Internal was due April 1 and funding rules have been updated.) To assist investigators who have temporarily lost significant federal research funding, and to facilitate carefully planned changes in research direction, the Emory School of Medicine offers a Bridge Funding Program. Bridge funding up to $100,000 (including Department support/matching funds) will be available to investigators based on merit, potential for renewal of external funding, and availability of SOM funds. | | Read More | |
| |
| | Through this RFP, it is our intent to support virtual programs for dermatologists & allergists on new emerging therapies for moderate-to-severe atopic dermatitis. Programs targeted towards reviewing data from canceled dermatology or allergy medical conferences are of particular interest. | | Read More | |
| |
| | Wake Forest Primate Signature Program provides access to nonhuman primates (NHPs) and related resources for studies that advance translational research. To assist new NHP researchers, the Program is providing funds for feasibility studies to be conducted using monkey-related resources. The objective is to facilitate the collection of data from NHPs in support of applications for extramural funding. Applications are open to faculty members or KL2 scholars of CTSA supported institutions. | | Read More | |
| |
| | A key innovation strategy is to promote interdisciplinary and cross-departmental and -divisional research. The SOM I3 Education Awards are soliciting proposals that highlight, promote, and disseminate innovations in medical education and training (degree programs and GME) that enhance the Emory SOM mission. Please note that the project start date is now listed as “TBD.” We will re-evaluate the start date when we review proposals and better understand where research stands across Emory at that time. | | Read More | |
| |
| | The National Human Genome Research Institute (NHGRI) announces the availability of funds to support the development and implementation of modules aimed at providing health care professionals with genomic medicine training. Topics include clinical use of genomic data, genomic tests, analysis of clinical genomic data, pharmacogenomics, use of genomic information for preventive medicine, etc. Development of training materials and/or curriculum needs to be within the scope of the parent grant. Application budgets are limited to $125,000 total costs per year. | | Read More | |
| |
| | AMAG Pharmaceuticals, Inc. is committed to funding research aimed at reducing the risk of premature birth and preeclampsia in order to improve the health of neonates and infants in the United States through its 2020 Prematurity and Preeclampsia Research Grants Program for a total of $250,000. Consideration will be given to basic or clinical research in maternal, fetal and neonatal/infant health. | | Read More | |
| |
| | The purpose of this Notice of Special Interest is to highlight the list of widely appreciated systematic barriers or translational science problems included in PAR-19-099 and PAR-19-100 to add the following topics of interest: Rural Health, Racial and Ethnic Disparities in Maternal Mortality, Applications for Machine Learning and Artificial Intelligence (AI), Veterans' Health. | | Read More | |
| |
| | The Certificate Program in Translational Research (CPTR) is a formal 16-credit Emory Laney Graduate School program for trainees who seek to conduct research at the interface between basic and translational science and clinical medicine. | | Read More | |
| |
| | The Medical Innovation Residency Track is a 24-month program now open to both Emory and MSM participants to provide a foundation of knowledge to participate in entrepreneurship and design for innovate technologies. Upon successful participation and completion of this track, residents will be awarded a certificate of distinction in Medical Innovation from Emory University School of Medicine. | | Read More | |
| |
| | Phlebotomy 101 is a two-day classroom and clinical, hands-on training to venipuncture offered through the Georgia CTSA Clinical Research Centers (GCRCs). The course is offered quarterly to research coordinators from Emory, Morehouse School of Medicine and UGA. | | Class Schedule | |
| |
| | The new Georgia CTSA Grant Wise service offers the opportunity for one-on-one feedback from experienced senior faculty on grant writing. We are soliciting experienced faculty to serve as volunteer mentors. If you have experience in writing grants and you enjoy mentoring, we need you! After completing the online volunteer form, we will be in touch should we receive a request that matches your expertise. Contact lauren.james@emory.edu | | Volunteer Form | |
| |
| | Many Emory investigators are pursuing essential and critical research projects focused on the COVID-19 pandemic. If you have plans to collect or are currently collecting samples from COVID-19 patients, please respond with a brief description of your work and the type of sample (DNA, serum, PBMCs) you need. Providing essential platforms to support COVID-19 research is a high priority. Requests for new equipment to directly support COVID-19 research are being collected via email. Please send email to Mike Zwick at mzwick@emory.edu. | | Read More | |
| |
| | CURE ID is an internet-based repository that lets the clinical community report novel uses of existing drugs for difficult-to-treat infectious diseases through a website, a smartphone or other mobile device. The platform enables the crowdsourcing of medical information from health care providers to guide potentially life-saving interventions and facilitate the development of new treatments for neglected diseases. CURE ID is a collaboration between the FDA and the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). | | Read More | |
| |
| | We are a community of medical professionals, life scientists and data scientists on a quest to defeat COVID-19. To pitch in, join our discourse! | | Read More | |
| |
| | The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. We hope to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. Consortium members manage a range of computing capabilities that span from small clusters to some of the very largest supercomputers in the world. Learn more about how to request access to resources of the COVID-19 HPC Consortium. | | Read More | |
| |
| | Georgia CTSA is now offering Virtual Studios to meet your research brainstorming needs. Our on-site presence has temporarily changed, but our desire to help you plan and collaborate regarding existing and potential research has not paused. Examples of areas where we have served past customers with expert brainstorming include locating collaborators and resources, hypothesis generation, study design, implementation, analysis and interpretation, translation and manuscript development of research topics. Contact the Georgia CTSA Coordinating Center by emailing Karen Lindsley at klindsl@emory.edu or Submit a Request for a Studio Consultation. | | Submit a Request | |
| |
| | Reproducibility: Ethics Podcasts in Research | | Read More | |
| |
| | Registration is now open for the SBIR Road Tour stopping at UGA in Athens, GA. National outreach effort connecting entrepreneurs working on advanced technologies to the country’s largest source of early stage funding – the SBIR/STTR programs. Opportunity for small businesses, innovators, researchers, entrepreneurs and technology companies to connect directly with SBIR/STTR program managers representing more than a dozen different federal agencies. SBIR/STTR programs provide over $3.7 billion in funding to small businesses each year in a wide variety of technology areas. | | Read More & Register | |
| |
| | | The Georgia CTSA recently partnered with the All of Us Research Program. All of Us is a health research program funded by the National Institutes of Health (NIH). Its goal is to help researchers better understand why people get sick or stay healthy. The mission of the All of Us Research Program is simple: to speed up health research and medical breakthroughs. To do this, All of Us is asking one million people from across the U.S. to share their health ... | | Read More | |
| |
| | Join us through Zoom from 1 pm- 2 pm if you have any questions regarding your upcoming projects. Although EIPC is not accepting any new samples until further notice, a chat with us now will help you to get up to speed quickly once the facility opens. | | Read More | |
| |
| | Join us through Zoom from 1pm- 2pm for a Division of Animal Resources operations update. | | Read More | |
| |
| | Interested in administrative data sets (e.g., PHIS, claims)? Come learn strategies to prevent your projects from PHISzling out! Join us through Zoom from 12 pm- 1 pm. | | Read More | |
| |
| | Join this free webinar from 2:00 - 3:00 p.m. to learn the pros and cons of different commercialization strategies to help determine the best fit for your technology. Our panel discussion format will allow you to ask questions and receive feedback to better understand complex go-to-market strategies. Please note all talks for the remainder of this series will be hosted via webinar. | | Register | |
| |
| | Please join our Georgia CTSA Clinical Research Centers (GCRCs) staff for a very special 60th Anniversary Open House showcase at the Emory University Hospital location, Unit HG-02. Tour and info sessions will be re-scheduled. | | Read More | |
| |
| | 2020 Statistical Methods in Imaging (SMI) Conference will be held at Emory Rollins School of Public Health (RSPH). The SMI conference is the annual meeting of the ASA Statistics in Imaging section. Please be aware that due to global concern over coronavirus, the dates of the conference are subject to change. | | Read More | |
| |
| | Georgia CTSA is proud to announce it is a Silver Sponsor of this year's conference at the Georgia Aquarium! Registration is open now. Georgia CTSA Innovation Catalyst Director Wilbur Lam, MD, PhD, is this year's co-chair. CME is also offered. | | Read More | |
| |
| | Come join us for this annual symposium event showcasing local basic and clinical research conducted by our fellows and junior faculty conducting pediatric research on Tuesday, August 4 at the Health Sciences Research Building Auditorium and Café. | | Read More | |
| |
| For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit
www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
GeorgiaCTSA@emory.edu.
Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382. |
| |
|